The history of the erectile dysfunction drug presents a challenging picture for investors. While the initial release generated significant profits, the end of its intellectual property protection opened the avenue to https://thebookmarkplaza.com/story21541641/the-copyright-and-the-pharmaceutical-industry-a-risky-investment